Community-acquired pneumonia: Clinical sciences

2,732views

test

00:00 / 00:00

Community-acquired pneumonia: Clinical sciences

Focused chief complaint

Abdominal pain

Approach to biliary colic: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Approach to pneumoperitoneum and peritonitis (perforated viscus): Clinical sciences
Approach to postoperative abdominal pain: Clinical sciences
Approach to upper abdominal pain: Clinical sciences
Abdominal aortic aneurysm: Clinical sciences
Acute coronary syndrome: Clinical sciences
Acute mesenteric ischemia: Clinical sciences
Acute pancreatitis: Clinical sciences
Adnexal torsion: Clinical sciences
Alcohol-induced hepatitis: Clinical sciences
Aortic dissection: Clinical sciences
Appendicitis: Clinical sciences
Approach to ascites: Clinical sciences
Cholecystitis: Clinical sciences
Choledocholithiasis and cholangitis: Clinical sciences
Chronic mesenteric ischemia: Clinical sciences
Chronic pancreatitis: Clinical sciences
Colonic volvulus: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Diverticulitis: Clinical sciences
Ectopic pregnancy: Clinical sciences
Endometriosis: Clinical sciences
Gastritis: Clinical sciences
Gastroesophageal reflux disease: Clinical sciences
Hepatitis A and E: Clinical sciences
Hepatitis B: Clinical sciences
Hepatitis C: Clinical sciences
Herpes zoster infection (shingles): Clinical sciences
Ileus: Clinical sciences
Infectious gastroenteritis: Clinical sciences
Inflammatory bowel disease (Crohn disease): Clinical sciences
Inflammatory bowel disease (ulcerative colitis): Clinical sciences
Inguinal hernias: Clinical sciences
Intra-abdominal abscess: Clinical sciences
Irritable bowel syndrome: Clinical sciences
Ischemic colitis: Clinical sciences
Large bowel obstruction: Clinical sciences
Lower urinary tract infection: Clinical sciences
Malaria: Clinical sciences
Nephrolithiasis: Clinical sciences
Paraesophageal and hiatal hernia: Clinical sciences
Peptic ulcer disease: Clinical sciences
Pulmonary embolism: Clinical sciences
Pyelonephritis: Clinical sciences
Rectus sheath hematoma: Clinical sciences
Retroperitoneal hematoma: Clinical sciences
Sickle cell disease: Clinical sciences
Small bowel obstruction: Clinical sciences
Spontaneous bacterial peritonitis: Clinical sciences
Testicular torsion (pediatrics): Clinical sciences

Altered mental status

Approach to altered mental status: Clinical sciences
Acute stroke (ischemic or hemorrhagic) or TIA: Clinical sciences
Alcohol withdrawal: Clinical sciences
Approach to encephalitis: Clinical sciences
Approach to epilepsy: Clinical sciences
Approach to hypercalcemia: Clinical sciences
Approach to hypernatremia: Clinical sciences
Approach to hypocalcemia: Clinical sciences
Approach to hypoglycemia: Clinical sciences
Approach to hyponatremia: Clinical sciences
Approach to hypothyroidism: Clinical sciences
Approach to increased intracranial pressure: Clinical sciences
Approach to mood disorders: Clinical sciences
Approach to schizophrenia spectrum and other psychotic disorders: Clinical sciences
Approach to shock: Clinical sciences
Approach to traumatic brain injury: Clinical sciences
Aspiration pneumonia and pneumonitis: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Delirium: Clinical sciences
Diabetic ketoacidosis: Clinical sciences
Hepatic encephalopathy: Clinical sciences
Hospital-acquired and ventilator-associated pneumonia: Clinical sciences
Hyperosmolar hyperglycemic state: Clinical sciences
Hypothermia: Clinical sciences
Hypovolemic shock: Clinical sciences
Lower urinary tract infection: Clinical sciences
Meningitis and brain abscess: Clinical sciences
Opioid intoxication and overdose: Clinical sciences
Opioid withdrawal syndrome: Clinical sciences
Pyelonephritis: Clinical sciences
Subarachnoid hemorrhage: Clinical sciences
Substance use disorder: Clinical sciences
Uremic encephalopathy: Clinical sciences

Assessments

USMLE® Step 2 questions

0 / 4 complete

Decision-Making Tree

Questions

USMLE® Step 2 style questions USMLE

0 of 4 complete

A 65-year-old man presents to the emergency department for evaluation of dyspnea and a productive cough. Symptoms developed two days ago and have progressively worsened. Medical history is notable for type II diabetes mellitus, cirrhosis and prior left foot osteomyelitis due to Pseudomonas aeruginosa. Temperature is 39.0 °C (102.2 °F), blood pressure is 136/75 mmHg, pulse is 96/min, respiratory rate is 20/min, and oxygen saturation is 95% on room air. Auscultation of the lungs is significant for crackles and decreased breath sounds in the right lower lobe. Blood glucose is 290 mg/dL. A chest radiograph shows a right lower lobe consolidation. In addition to azithromycin, which of the following medications should be administered?  

Transcript

Watch video only

Pneumonia is a lung infection that results in inflammation of one or both lungs. Usually, it is caused by bacteria, like Streptococcus pneumoniae; and viruses, such as influenza, but rarely, pneumonia can be caused by fungi as well.

Now, based on the setting in which pneumonia develops, we can subdivide it into two main types: community-acquired pneumonia, or CAP for short; and hospital-acquired pneumonia, or HAP. When a person develops pneumonia outside of a hospital or within 48 hours after the admission to hospital, it’s considered CAP.

On the other hand, HAP develops after 48 hours of the admission to hospital. Finally, there’s a special subtype of HAP called ventilator-acquired pneumonia, or VAP. VAP refers to pneumonia that occurs in individuals on mechanical ventilation, 48 hours after the endotracheal intubation.

The first thing to do when approaching a patient with suspected CAP is to obtain a focused history and physical examination; send labs, such as ABG, CBC and BMP; monitor pulse oximetry; and get a chest x-ray.

Let’s start with the history. Patients with CAP might report coughing, difficulty breathing, and chest pain during inspiration. Keep in mind that these symptoms develop either outside of the hospital or within 48 hours of admission. They may also have a history of risk factors like COPD, diabetes, smoking, or alcohol use.

Here are some high-yield facts to keep in mind! A productive cough can occur with bacterial infections. However, if the sputum is blood-tinged, consider specific organisms like Streptococcus pneumoniae, Klebsiella pneumoniae, or Legionella pneumophila.

Now, the physical examination often reveals an elevated temperature, tachypnea, and tachycardia. Pay close attention to lung auscultation, which might reveal rales over the affected area. Additionally, if there’s lobar consolidation, the physical exam might demonstrate bronchial breath sounds, egophony, and increased tactile fremitus in the affected lobe.

In contrast, patients with a pleural effusion might present with decreased breath sounds, decreased tactile fremitus, and dullness to chest percussion in the affected area.

Finally, pulse oximetry might reveal a drop in oxygen saturation, while chest X-ray can show new lung infiltrates.

Once you diagnosed CAP based on the history and physical, labs, and imaging studies, the next step is to determine its severity. This is where the pneumonia severity index, or PSI, comes in. PSI categorizes patients into 5 classes based on clinical elements like age and temperature; laboratory elements, such as BUN and glucose; and radiographic elements, like pleural effusion.

Now, let’s talk about low-risk CAP. Classes 1 to 3 are considered low-risk CAP and can be managed at home. The type of treatment is based on whether or not the person has any chronic medical conditions. So, if your patient has no chronic conditions, start them on oral amoxicillin or doxycycline for 5 days. However, if they do have a chronic condition, such as COPD or diabetes mellitus, then make sure to start them on an oral respiratory fluoroquinolone like levofloxacin or moxifloxacin, or a combination of an oral beta-lactam and a macrolide for 5 days.

Okay, let’s switch gears and talk about high-risk CAP. Classes 4 and 5 are considered high-risk CAP and require admission to the hospital. First, use the Infectious Diseases Society of America/ American Thoracic Society CAP criteria, better known as IDSA/ATS CAP criteria, to determine if they should be managed on the hospital floor, or in the ICU. IDSA/ATS CAP criteria include major criteria, such as septic shock or respiratory failure; and minor criteria, like elevated respiratory rate, confusion, uremia, high WBC count, low platelets, hypothermia, multilobar infiltrates, and hypotension.

Now, if your patient has no major or less than 3 minor criteria, admit them to the hospital floor and start them on supplemental oxygen to maintain oxygen saturation above 92%. Additionally, you should look for a causative pathogen, so don’t forget to obtain a blood culture, and a sputum sample for culture and gram stain. You can also test the urine and sputum for pneumococcal antigens. Finally, assess their symptoms daily to check how they are responding to treatment.

If your patient has 1 major or 3 or more minor criteria, admit them to the ICU and start the same treatment as you do for hospital floor patients. Additionally, if the patient presents with respiratory failure, put them on ventilatory support and periodically assess parameters to optimize oxygenation. However, if the patient presents with sepsis, you should also maintain their systolic blood pressure above 90 mmHg using IV fluids and vasopressors.

Sources

  1. "Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. 200(7):e45-e67." Am J Respir Crit Care Med. (2019)
  2. "Comparing the pneumonia severity index with CURB-65 in patients admitted with community acquired pneumonia. 40(4):293-300." Scand J Infect Dis. (2008)
  3. "The Pneumonia Severity Index: A Decade after the Initial Derivation and Validation" Clinical Infectious Diseases (2008)
  4. "Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia" Chest (2022)
  5. "Addendum: Cillóniz, C.; Dominedò, C.; Nicolini, A.; Torres, A. PES Pathogens in Severe Community-Acquired Pneumonia. Microorganisms 2019, 7, 49" Microorganisms (2019)
  6. "Management of pneumonia in critically ill patients" BMJ (2021)
  7. "Understanding the Host in the Management of Pneumonia. An Official American Thoracic Society Workshop Report" Annals of the American Thoracic Society (2021)
  8. "Community-acquired pneumonia in the emergency department. 23(2):1-24." Emerg Med Pract. (2021)
  9. "Nucleic Acid–based Testing for Noninfluenza Viral Pathogens in Adults with Suspected Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline. 203(9):1070-1087." Am J Respir Crit Care Med. (2021)
  10. "An Algorithm for the Selection of Probes for Specific Detection of Human Disease Pathogens Using the DNA Microarray Technology" Sovremennye tehnologii v medicine (2022)
  11. "The SIRS criteria have better performance for predicting infection than qSOFA scores in the emergency department" Scientific Reports (2020)
  12. "A profile of delafloxacin in the treatment of adults with community-acquired bacterial pneumonia" Expert Review of Clinical Pharmacology (2022)
  13. "Validation and comparison of three mortality prediction scores in emergency department patients with community-acquired pneumonia." Colombia Medica (2021)
  14. "A prediction model for hospital mortality in patients with severe community-acquired pneumonia and chronic obstructive pulmonary disease" Respiratory Research (2022)
  15. "Concomitant occurrence of primary renal non-Hodgkin lymphoma and a colon cancer" Medicine (2019)
  16. "Performance of the CURB-65 Score in Predicting Critical Care Interventions in Patients Admitted With Community-Acquired Pneumonia" Annals of Emergency Medicine (2019)
  17. "Immunocompetent HA, Emergence OV, COVID A, County MK. Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among US Adults: Updated Recommendations of the Advisory Committee on Immunization Practices—United States, 2022." Notes (2022)
  18. "Comparison between the Severity Scoring Systems A-DROP and CURB-65 for Predicting Safe Discharge from the Emergency Department in Patients with Community-Acquired Pneumonia" Emergency Medicine International (2022)
  19. "The Berlin definition of acute respiratory distress syndrome: should patients receiving high-flow nasal oxygen be included?" The Lancet Respiratory Medicine (2021)
  20. "The Use of the SMART-COP Score in Predicting Severity Outcomes Among Patients With Community-Acquired Pneumonia: A Meta-Analysis" Cureus (2022)
  21. "Community-acquired pneumonia: Strategies for triage and treatment" Cleveland Clinic Journal of Medicine (2020)
  22. "Emergency management of community-acquired bacterial pneumonia: what is new since the 2007 Infectious Diseases Society of America/American Thoracic Society guidelines. 31(3):602-612." Am J Emerg Med. (2013)
  23. "Updates on community acquired pneumonia management in the ICU" Pharmacology & Therapeutics (2021)
  24. "The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission—a living systematic review" Clinical Microbiology and Infection (2021)
  25. "Outcome of acute hypoxaemic respiratory failure: insights from the LUNG SAFE Study. 57(6):2002836" Eur Respir J. (2021)
  26. "Unmet needs in pneumonia research: a comprehensive approach by the CAPNETZ study group" Respiratory Research (2022)
  27. "Performance of the CORB (Confusion, Oxygenation, Respiratory Rate, and Blood Pressure) Scale for the Prediction of Clinical Outcomes in Pneumonia" Canadian Respiratory Journal (2022)
  28. "Cost impact analysis of novel host-response diagnostic for patients with community-acquired pneumonia in the emergency department" Journal of Medical Economics (2022)
  29. "Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR)" Trials (2022)
  30. "Prediction value of procalcitonin combining CURB-65 for 90-day mortality in community-acquired pneumonia. Expert Rev 15(5):689-696." Respir Med. (2021)
  31. "qSOFA as a new community-acquired pneumonia severity score in the emergency setting" Emergency Medicine Journal (2020)
  32. "Predictive factors and outcomes of severe community acquired pneumonia in patients with respiratory failure" Pakistan Journal of Medical Sciences (2022)
  33. "Diagnostic stewardship aiming at expectorated or induced sputum promotes microbial diagnosis in community-acquired pneumonia" BMC Infectious Diseases (2022)
  34. "Clinical metagenomics assessments improve diagnosis and outcomes in community-acquired pneumonia" BMC Infectious Diseases (2021)
  35. "Nomogram for predicting in‐hospital mortality of nonagenarians with community‐acquired pneumonia" Geriatrics & Gerontology International (2022)
  36. "Community-Acquired Pneumonia: Updated Recommendations from the ATS and IDSA. " Am Fam Physician. (2020;102(2):121-124. )
  37. "Community-acquired pneumonia. " Lancet (2015;386(9998):1097-108. )